第一医药(600833) - 2019 Q1 - 季度财报

Financial Performance - Net profit attributable to shareholders increased by 22.62% to CNY 14,117,679.49 compared to the same period last year[7] - Operating revenue decreased by 1.72% to CNY 307,984,638.80 compared to the same period last year[7] - Basic and diluted earnings per share increased by 22.67% to CNY 0.0633[7] - The company's operating profit for Q1 2019 was CNY 18,598,160.07, up from CNY 15,134,318.55 in Q1 2018, indicating a growth of 22.4%[19] - The net profit for Q1 2019 reached CNY 14,117,679.49, representing an increase of 22.67% from CNY 11,513,280.85 in Q1 2018[19] - The company's operating cash flow net amount was CNY 45,253,757.10, an increase of 13.4% compared to CNY 39,912,647.03 in Q1 2018[23] Assets and Liabilities - Total assets increased by 15.46% to CNY 1,246,313,218.27 compared to the end of the previous year[7] - Total liabilities increased to CNY 341,644,289.12 in Q1 2019, compared to CNY 285,646,863.65 in Q4 2018, marking a rise of 19.6%[18] - Current assets totaled CNY 589,347,250.70, an increase of 7.8% from CNY 546,579,036.94 at the end of 2018[18] - Non-current assets totaled CNY 479,005,530.19, an increase of 26.5% from CNY 378,653,985.48 at the end of 2018[18] - Total current assets amounted to RMB 546,579,036.94, with cash and cash equivalents at RMB 354,553,901.15[28] - Total liabilities reached RMB 285,646,863.65, with current liabilities accounting for RMB 240,103,014.76[31] Cash Flow - Net cash flow from operating activities decreased by 16.13% to CNY 46,615,747.09 compared to the same period last year[7] - Total cash inflow from operating activities was CNY 155,664,629.47, down 42.1% from CNY 268,592,085.08 in the same period last year[23] - Cash outflow from operating activities totaled CNY 110,410,872.37, a decrease of 51.6% compared to CNY 228,679,438.05 in Q1 2018[23] - Cash and cash equivalents at the end of Q1 2019 totaled ¥433,001,161.83, an increase from ¥374,686,108.15 at the end of Q1 2018[22] Shareholder Information - The total number of shareholders reached 24,730 at the end of the reporting period[8] - The largest shareholder, Bailian Group, holds 44.60% of the total shares, amounting to 99,488,634 shares[8] - Bailian Group has increased its holdings by 1,467,440 shares, representing 0.658% of the total share capital[10] Other Financial Metrics - The weighted average return on equity increased by 0.34 percentage points to 1.99%[7] - Other comprehensive income increased by 64.32% to 197,151,422.70 from 119,983,132.55[11] - Other income increased significantly by 9,354.44% to 8,958,857.92 from 94,758.18[11] - The company received government subsidies amounting to CNY 8,958,857.92, which are closely related to its normal business operations[6] Changes in Accounts - Accounts receivable decreased by 100% to 0 from 1,500,000.00[11] - Prepayments increased by 34.69% to 9,454,123.61 from 7,019,098.21[11] - Other receivables increased by 54.13% to 8,557,512.00 from 5,552,037.98[11] - Long-term equity investments increased by 57.17% to 824,745.26 from 524,745.26[11] - Construction in progress increased by 108.52% to 3,105,536.74 from 1,489,317.27[11] - Deferred income tax liabilities increased by 64.21% to 65,782,847.26 from 40,060,083.87[11] Financial Reporting Standards - The company executed new financial accounting standards starting January 1, 2019, which may impact future financial reporting[27] - The company executed new financial accounting standards effective January 1, 2019, impacting the reporting of financial instruments[32]